Tuesday, 21 October 2014
Last updated 6 min ago
Aug 20 2012 | 8:34am ET
Institutional brokerage and execution firm WallachBeth Capital has launched a healthcare research platform staffed by a six-member team from Auriga USA.
Senior managing directors Douglas Bantum and Gene McNeil Jr. will lead the new WallachBeth division.The two were co-heads of equity sales and trading for Auriga USA (a subsidiary of Madrid-based Auriga Global Investors) and previously worked together at the institutional research boutique Capstone Investments.
Additional members of the research team include Anthony Politi, Peter McDonald, Glen Losev and Difei Yang.
The new group will focus on company analysis, information flow, conflict-free investment ideas and access to industry thought leaders across key healthcare verticals.
Said WallachBethCapital CEO Michael Wallach in a statement, “We formed a small boutique less than five years ago…We’ve since grown exponentially and now have a 50+ team of professionals serving a broad client base in multiple product areas. Offering a value-added, proprietary equity research product specific to innovative companies within the healthcarevertical enables us to extend our role as a niche provider of in-demand, yet under-served markets, and further complements our mission to provide true best execution.”
Sep 22 2014 | 4:15pm ET
"I tell people that everybody likes good news and so if you have good performance that’s wonderful,” explains Mike McKitish of Peddie School's endowment, “but it’s the people that want to talk about the bad news or where they drifted and how they came back and how they stayed to their discipline…” that he wants to hear from. Read more…
Sep 30 2014 | 9:29am ET
The crisp Autumnal days of October are upon us, and so are a few of the hedge fund industry’s favorite charitable events. If you have never been to Rocktoberfest, well, you are missing out. And for a quieter evening of sipping and socializing, stop by HFC’s Wine Soiree. Read more…
Most traders agree that proper risk management is the key to successful trading. However, many traders depend on the deeply flawed measure of standard deviation as a benchmark of risk. Here we put it ...